We invest in new frontiers of science to address global health challenges through paradigm-shifting drugs, vaccines, biologics, and gene therapies.

13 мар. 2024 г. · BioNTech accounts for 17.5% of the Bill and Melinda Gates Foundation portfolio, which owns almost 148,000 shares valued at $15.7 million. That's ...

BIO Ventures for Global Health today announced it will expand its efforts to enlist biotechnology companies in the fight to improve global health.

Gates Is Part of a $275 Million Investment in Ginkgo Bioworks, an Organism Engineering Startup · Ginkgo Bioworks Is Now a Financial 'Unicorn' Valued at $1 ...

Bill & Melinda Gates Foundation invests $55 million in an infectious disease collaboration that could reach up to $100 million in total funding.

“Investment in vaccines can bring a 16-fold return, and a $1 investment can result in $16 in savings through disease prevention,” said Jerome Kim (58), IVI ...

The Bill & Melinda Gates Foundation sold off almost all its pharmaceutical, biotechnology, and healthcare investments, the Wall Street Journal reports.

12 мая 2024 г. · The Breakthrough-backed European companies · Mission Zero · Heart Aerospace · Blue World Technologies · Dioxycle · H2site · Reactive Technologies.

26 апр. 2023 г. · Bill Gates's March Venture Investments: Biotech, Energy, And Taking On Methane Emissions ... In addition to Gates's personal investments, ...

4 мар. 2021 г. · Bill Gates-backed Oxford biotech totals $100M funding to discover new drugs using AI · Autonomous drug design · AI-first drug discovery platform.